TSX:BLU (BELLUS Health Inc.)
About BLU
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
Financial Market Data copyright © 2024
QuoteMedia. Data delayed 15 minutes unless otherwise
indicated (view
delay times for all exchanges).
RT=Real-Time, EOD=End of Day,
PD=Previous Day. Market
Data powered by QuoteMedia.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Profiles by Morningstar.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Financials by Morningstar.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia. Data delayed 15 minutes unless otherwise
indicated (view
delay times for all exchanges).
RT=Real-Time, EOD=End of Day,
PD=Previous Day. Market
Data powered by QuoteMedia.
Terms of Use.
Financial Market Data copyright © 2024
QuoteMedia. Data delayed 15 minutes unless otherwise
indicated (view
delay times for all exchanges).
RT=Real-Time, EOD=End of Day,
PD=Previous Day. Market
Data powered by QuoteMedia.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Share Information by Morningstar.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Dividends by EDI/Mergent (USA) and TSX (CDN).
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Earnings and Analyst Ratings by Zacks.
Earnings Events by Wall Street Horizon.
Terms of Use.
BELLUS Health Inc. (TSX: BLU) Latest News
Investing
Why BELLUS Health (TSX:BLU) Stock Jumped 30% on the TSX Today!
Energy Stocks
3 Bargain TSX Stocks to Buy While They’re Low
Cannabis Stocks
3 Top Growth Stocks to Own Before They Take Off
Dividend Stocks
Got $2,000? 4 Top Stocks to Buy This Month
Investing
TFSA Investors: This Pharma Stock Could Rise Significantly
Cannabis Stocks
2 TSX Stocks That Could Return 100% in 2021
Investing
Warren Buffett Is Betting Big on Drug Stocks
Investing
2 Top Oversold Stocks in the Coronavirus Market Crash
Metals and Mining Stocks
Canada Revenue Agency: 1 Major TFSA Mistake Could Cost You Thousands
Investing
This Little-Known Stock Increased Over 100% in 2019!
Investing
This Biotech Stock Is Set to Climb 500%